Pulmonology Medical News about Tiotropium

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Tiotropium bromide for chronic obstructive pulmonary disease
Expert Review of Respiratory Medicine, 06/17/09

Mamary AJ et al. - Tiotropium is associated with increased lung function, health-related quality of life and exercise tolerance, and reduced dyspnea and acute exacerbations of COPD. It has been hypothesized that tiotropium may retard the accelerated decline in lung function associated with COPD. Tiotropium is safe and well-tolerated, with few side effects. Herein, the authors discuss the pharmacology, physiology and safety profile of tiotropium, as well as the clinical studies that have demonstrated its efficacy in COPD.

<< Previous
Primary care delivery, risk pooling and economic efficiency

Next >>
Alternatives to positive airway pressure for obstructive sleep...